Literature DB >> 26056557

Cyclic headaches in β-thalassemia intermedia case presenting as moyamoya syndrome.

Süha Akpınar1, Güliz Yılmaz1, Emre Çelebioğlu2.   

Abstract

Entities:  

Keywords:  Cerebrovascular; Headache; Moyamoya; Β-Thalassemia

Year:  2015        PMID: 26056557      PMCID: PMC4449392     

Source DB:  PubMed          Journal:  Iran J Neurol        ISSN: 2008-384X


× No keyword cloud information.
Moyamoya disease is a cerebrovascular disorder with unknown cause characterized by the occlusion of the bilateral internal carotid arteries (ICA) and proximal segments of ICA.[1],[2] On the other hand, moyamoya syndrome (MMS) is a rare form of this condition with underlying several pathologies including hematologic disorders, congenital syndromes, vascular malformations or vasculitis after irradiation, infections, and head trauma.[1] The symptoms of MMS are headache, seizure, and recurrent transient ischemic attacks. MMS frequently presents with the symptoms of occlusion in children, whereas in adults, the symptoms are mainly due to subarachnoid hemorrhage.[3] The collateral vessels which is a compensatory mechanism occur as a result of obstruction that resemble puff of smoke on digital subtraction angiography and magnetic resonance angiography (MRA).[1],[2] A β-thalassemia intermedia patient of 51 with cyclic headaches was investigated using MR imaging which demonstrated focal chronic infarcts and on MRA bilateral ICA were occluded at the level of petrous segment whereas vascular supply was from external carotid artery and by collateral development. At the posterior circulation, microangiopathic collaterals at thalamus and basal ganglia were detected originating from basilar artery and its branches (Figure 1a-c).
Figure 1

(a) Axial T2-weighted magnetic resonance (MR) image shows microvascular collaterals at the level of perimesencephalic cisterns and vascular supply to anterior cerebral artery and middle cerebral artery at the anterior circulation (arrows). (b) Axial MR angiography image reveals microangiopathic collaterals at the posterior circulation originating from basilar artery and its branches (black arrow). There was vascular supply from an external carotid artery by collateral development (white arrow) and bilateral internal carotid arteries occlusion at the petrous segment. (c) Axial MR angiography image demonstrates microangiopathic collaterals resembling puff of smoke (moyamoya vessels) at thalamus and basal ganglia (arrows).

Few cases of MMS with β-thalassemia reported were under the age of 20 in our research of the literature. Among hemoglobinopathies, β-thalassemia intermedia is very rarely associated with MMS however, sickle cell anemia is the most frequent type.[4] Although silent strokes could be detected in the young patients, with the progression of moyamoya vessels we did not find any ischemic changes in our 51-year-old patient on MRI.[5] This β-thalassemia intermedia patient is an exclusive MMS case with the findings of cerebrovascular occlusion and collateral vessels demonstrated on MRA which is the preferred noninvasive imaging modality in the diagnosis. (a) Axial T2-weighted magnetic resonance (MR) image shows microvascular collaterals at the level of perimesencephalic cisterns and vascular supply to anterior cerebral artery and middle cerebral artery at the anterior circulation (arrows). (b) Axial MR angiography image reveals microangiopathic collaterals at the posterior circulation originating from basilar artery and its branches (black arrow). There was vascular supply from an external carotid artery by collateral development (white arrow) and bilateral internal carotid arteries occlusion at the petrous segment. (c) Axial MR angiography image demonstrates microangiopathic collaterals resembling puff of smoke (moyamoya vessels) at thalamus and basal ganglia (arrows).
  5 in total

1.  Guidelines for the diagnosis and treatment of spontaneous occlusion of the circle of Willis ('moyamoya' disease). Research Committee on Spontaneous Occlusion of the Circle of Willis (Moyamoya Disease) of the Ministry of Health and Welfare, Japan.

Authors:  M Fukui
Journal:  Clin Neurol Neurosurg       Date:  1997-10       Impact factor: 1.876

2.  Beta-thalassemia intermedia associated with moyamoya syndrome.

Authors:  Basak Karakurum Göksel; Hakan Ozdogu; Tulin Yildirim; Levent Oğuzkurt; Suheyl Asma
Journal:  J Clin Neurosci       Date:  2010-07       Impact factor: 1.961

3.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

4.  Moyamoya disease associated with hemoglobin Fairfax and beta-thalassemia.

Authors:  Franklin A Marden; Christopher M Putman; John M Grant; Jay Greenberg
Journal:  Pediatr Neurol       Date:  2008-02       Impact factor: 3.372

5.  Diagnosis of moyamoya disease with magnetic resonance angiography.

Authors:  K Houkin; T Aoki; A Takahashi; H Abe
Journal:  Stroke       Date:  1994-11       Impact factor: 7.914

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.